Vieceli et al.
| |
ICC I95CI%): 0.43 (0.38–0.47)
|
ICC (95CI%): 0.37 (0.32–0.41)
|
ICC (95CI%): 0.17 (0.13–0.22)
|
ICC (95CI%): 0.61 (0.58–0.65)
|
Nakakubo et al.
|
MD ± LOA: 0.00 ± 2.10
| |
ICC (95CI%): 0.38 (0.35–0.43)
|
ICC (95CI%): 0.16 (0.12–0.21)
|
ICC (95CI%): 0.44 (0.40–0.48)
|
Tordjman et al.
|
MD ± LOA: 0.00 ± 2.20
|
MD ± LOA: 0.00 ± 2.17
| |
ICC (95CI%): 0.10 (0.055–0.15)
|
ICC (95CI%): 0.46 (0.43–0.50)
|
Aldobyany et al.
|
MD ± LOA: 0.00 ± 2.52
|
MD ± LOA: 0.00 ± 2.53
|
MD ± LOA: 0.00 ± 2.62
| |
ICC (95CI%): 0.17 (0.12–0.22)
|
Kurstjen et al.
|
MD ± LOA: 0.00 ± 1.72
|
MD ± LOA: 0.00 ± 2.08
|
MD ± LOA: 0.00 ± 2.03
|
MD ± LOA: 0.00 ± 2.53
| |